RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Bereket Mochona to Drug Design

Back to Details
This is a "connection" page, showing publications Bereket Mochona has written about Drug Design.
Bereket Mochona
Connection Strength
0.498
Drug Design
  1. Mochona B, Qi X, Euynni S, Sikazwi D, Mateeva N, Soliman KF. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents. Bioorg Med Chem Lett. 2016 06 15; 26(12):2847-2851.
    View in: PubMed
    Score: 0.498
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support